1. Impact of the COVID-19 pandemic on the management of patients with end-stage renal disease
- Author
-
Der Cherng Tarng, Yu Jiun Chan, Yu Shuo Tang, and Szu Yuan Li
- Subjects
medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Risk of infection ,General Medicine ,Disease ,030204 cardiovascular system & hematology ,Peritoneal dialysis ,End stage renal disease ,03 medical and health sciences ,0302 clinical medicine ,Personal hygiene ,Infectious disease (medical specialty) ,030220 oncology & carcinogenesis ,Pandemic ,medicine ,Hemodialysis ,Intensive care medicine ,business - Abstract
A novel infectious disease, coronavirus disease-2019 (COVID-19), spread globally since December 2019. Without effective treatment and vaccination, the strategies to restrain this disease are only keeping social distance, maintaining personal hygiene, quarantine, and isolation. However, thrice-a-week treatment is inevitable for all hemodialysis patients. In addition to the high risk of cluster infection and compromised immunity in patients with end-stage renal disease (ESRD), an atypical disease presentation could also make the medial system neglect these patients during CVOID-19 pandemic. To avoid COVID-19 transmission among patients on dialysis, the major societies of nephrology around the world have provided their guidelines for screening, dialysis facilities adjustment, and health education, respectively. In this review, we summarized the main contents and differences of these guidelines and addressed the prompt management for patients with ESRD to reduce the risk of infection during COVID-19 pandemic.
- Published
- 2020